HEADER DE NOVO PROTEIN 11-MAY-17 5VSG
TITLE FIBRILS OF THE SUPER HELICAL REPEAT PEPTIDE, SHR-FF, GROWN AT ELEVATED
TITLE 2 TEMPERATURE
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: SUPER HELICAL REPEAT PEPTIDE SHR-FF;
COMPND 3 CHAIN: A;
COMPND 4 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 SYNTHETIC: YES;
SOURCE 3 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT;
SOURCE 4 ORGANISM_TAXID: 32630;
SOURCE 5 OTHER_DETAILS: DE NOVO DESIGN
KEYWDS FIBRIL, DE NOVO DESIGN, DE NOVO PROTEIN
EXPDTA X-RAY DIFFRACTION
AUTHOR S.MONDAL,M.R.SAWAYA,D.S.EISENBERG,E.GAZIT
REVDAT 3 01-JAN-20 5VSG 1 REMARK
REVDAT 2 10-JUL-19 5VSG 1 JRNL
REVDAT 1 27-JUN-18 5VSG 0
JRNL AUTH S.MONDAL,G.JACOBY,M.R.SAWAYA,Z.A.ARNON,L.ADLER-ABRAMOVICH,
JRNL AUTH 2 P.REHAK,L.VUKOVIC,L.J.W.SHIMON,P.KRAL,R.BECK,E.GAZIT
JRNL TITL TRANSITION OF METASTABLE CROSS-ALPHA CRYSTALS INTO
JRNL TITL 2 CROSS-BETA FIBRILS BY BETA-TURN FLIPPING.
JRNL REF J.AM.CHEM.SOC. V. 141 363 2019
JRNL REFN ESSN 1520-5126
JRNL PMID 30532955
JRNL DOI 10.1021/JACS.8B10289
REMARK 2
REMARK 2 RESOLUTION. 1.10 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.8.0135
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : NULL
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.10
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 16.76
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 89.3
REMARK 3 NUMBER OF REFLECTIONS : 1195
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.117
REMARK 3 R VALUE (WORKING SET) : 0.114
REMARK 3 FREE R VALUE : 0.134
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 12.000
REMARK 3 FREE R VALUE TEST SET COUNT : 163
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.10
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.13
REMARK 3 REFLECTION IN BIN (WORKING SET) : 50
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 53.57
REMARK 3 BIN R VALUE (WORKING SET) : 0.2020
REMARK 3 BIN FREE R VALUE SET COUNT : 10
REMARK 3 BIN FREE R VALUE : 0.2030
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 53
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 0
REMARK 3 SOLVENT ATOMS : 2
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 8.29
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -0.19000
REMARK 3 B22 (A**2) : 0.12000
REMARK 3 B33 (A**2) : 0.05000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.15000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.038
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.034
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.029
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.473
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.988
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.988
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 54 ; 0.012 ; 0.020
REMARK 3 BOND LENGTHS OTHERS (A): 49 ; 0.002 ; 0.020
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 77 ; 1.827 ; 2.138
REMARK 3 BOND ANGLES OTHERS (DEGREES): 106 ; 0.680 ; 3.000
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 6 ; 5.379 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 2 ;16.441 ;20.000
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 4 ;12.293 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 7 ; 0.072 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 60 ; 0.007 ; 0.020
REMARK 3 GENERAL PLANES OTHERS (A): 16 ; 0.001 ; 0.020
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): 103 ; 0.446 ; 3.000
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 104 ; 1.865 ; 5.000
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : NULL
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : NULL
REMARK 3 ION PROBE RADIUS : NULL
REMARK 3 SHRINKAGE RADIUS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY
REMARK 4
REMARK 4 5VSG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-MAY-17.
REMARK 100 THE DEPOSITION ID IS D_1000227908.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 05-MAR-17
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 7.4
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 24-ID-E
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 1367
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.100
REMARK 200 RESOLUTION RANGE LOW (A) : 100.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 89.2
REMARK 200 DATA REDUNDANCY : 3.600
REMARK 200 R MERGE (I) : 0.16500
REMARK 200 R SYM (I) : NULL
REMARK 200 FOR THE DATA SET : 6.5000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.10
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.14
REMARK 200 COMPLETENESS FOR SHELL (%) : 53.5
REMARK 200 DATA REDUNDANCY IN SHELL : 1.90
REMARK 200 R MERGE FOR SHELL (I) : 0.30800
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO PHASING
REMARK 200 SOFTWARE USED: SHELXD
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 50.60
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 5% DMSO, 100 MM HEPES, PH 7.4, BATCH
REMARK 280 MODE, TEMPERATURE 310K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 10.44150
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 -5.34300
REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000
REMARK 350 BIOMT1 3 1.000000 0.000000 0.000000 5.34300
REMARK 350 BIOMT2 3 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000
REMARK 350 BIOMT1 4 1.000000 0.000000 0.000000 -10.68600
REMARK 350 BIOMT2 4 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000
REMARK 350 BIOMT1 5 1.000000 0.000000 0.000000 10.68600
REMARK 350 BIOMT2 5 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 5 0.000000 0.000000 1.000000 0.00000
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 AIB A 2 -130.70 46.73
REMARK 500
REMARK 500 REMARK: NULL
DBREF 5VSG A 1 7 PDB 5VSG 5VSG 1 7
SEQRES 1 A 7 SER AIB PHE SER AIB PHE AIB
HET AIB A 2 6
HET AIB A 5 6
HET AIB A 7 7
HETNAM AIB ALPHA-AMINOISOBUTYRIC ACID
FORMUL 1 AIB 3(C4 H9 N O2)
FORMUL 2 HOH *2(H2 O)
LINK C SER A 1 N AIB A 2 1555 1555 1.33
LINK C AIB A 2 N PHE A 3 1555 1555 1.34
LINK C SER A 4 N AIB A 5 1555 1555 1.33
LINK C AIB A 5 N PHE A 6 1555 1555 1.33
LINK C PHE A 6 N AIB A 7 1555 1555 1.34
CRYST1 5.343 20.883 16.795 90.00 93.90 90.00 P 1 21 1 2
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.187161 0.000000 0.012756 0.00000
SCALE2 0.000000 0.047886 0.000000 0.00000
SCALE3 0.000000 0.000000 0.059680 0.00000
ATOM 1 N SER A 1 1.958 7.242 12.512 1.00 8.82 N
ANISOU 1 N SER A 1 1064 1103 1181 -32 -168 -63 N
ATOM 2 CA SER A 1 2.006 6.219 13.597 1.00 9.21 C
ANISOU 2 CA SER A 1 1211 1136 1152 -27 -42 -48 C
ATOM 3 C SER A 1 2.885 6.761 14.725 1.00 8.87 C
ANISOU 3 C SER A 1 1195 1079 1092 -9 -50 13 C
ATOM 4 O SER A 1 3.565 7.774 14.558 1.00 8.04 O
ANISOU 4 O SER A 1 1125 1043 885 57 53 -18 O
ATOM 5 CB SER A 1 2.563 4.887 13.072 1.00 9.66 C
ANISOU 5 CB SER A 1 1305 1079 1285 -39 -69 -50 C
ATOM 6 OG SER A 1 3.977 4.914 13.008 1.00 10.16 O
ANISOU 6 OG SER A 1 1325 1258 1276 83 75 -84 O
HETATM 7 N AIB A 2 2.893 6.078 15.869 1.00 8.16 N
ANISOU 7 N AIB A 2 1035 986 1079 -16 -1 -20 N
HETATM 8 CA AIB A 2 3.708 6.504 17.020 1.00 8.26 C
ANISOU 8 CA AIB A 2 1107 987 1044 115 -61 9 C
HETATM 9 C AIB A 2 3.539 7.999 17.272 1.00 7.66 C
ANISOU 9 C AIB A 2 985 956 968 66 -13 68 C
HETATM 10 O AIB A 2 2.409 8.471 17.280 1.00 7.76 O
ANISOU 10 O AIB A 2 986 938 1024 84 -107 141 O
HETATM 11 CB1 AIB A 2 3.250 5.787 18.277 1.00 8.20 C
ANISOU 11 CB1 AIB A 2 1021 1009 1086 -18 -76 19 C
HETATM 12 CB2 AIB A 2 5.138 6.074 16.753 1.00 8.34 C
ANISOU 12 CB2 AIB A 2 1044 1029 1094 41 -80 53 C
ATOM 13 N PHE A 3 4.630 8.761 17.425 1.00 7.41 N
ANISOU 13 N PHE A 3 958 957 899 89 -22 0 N
ATOM 14 CA PHE A 3 4.572 10.201 17.759 1.00 7.52 C
ANISOU 14 CA PHE A 3 968 962 924 12 -15 -21 C
ATOM 15 C PHE A 3 4.667 11.107 16.548 1.00 7.95 C
ANISOU 15 C PHE A 3 1096 967 956 -213 28 -22 C
ATOM 16 O PHE A 3 4.710 12.333 16.668 1.00 8.83 O
ANISOU 16 O PHE A 3 1239 946 1166 -148 -240 17 O
ATOM 17 CB PHE A 3 5.698 10.538 18.738 1.00 8.04 C
ANISOU 17 CB PHE A 3 999 1082 973 -57 -15 -67 C
ATOM 18 CG PHE A 3 5.658 9.687 19.951 1.00 7.82 C
ANISOU 18 CG PHE A 3 953 1030 988 -145 -95 -69 C
ATOM 19 CD1 PHE A 3 4.619 9.831 20.815 1.00 9.63 C
ANISOU 19 CD1 PHE A 3 1233 1272 1154 214 90 3 C
ATOM 20 CD2 PHE A 3 6.586 8.686 20.182 1.00 8.03 C
ANISOU 20 CD2 PHE A 3 1072 1045 935 -65 -56 -120 C
ATOM 21 CE1 PHE A 3 4.517 9.035 21.929 1.00 9.97 C
ANISOU 21 CE1 PHE A 3 1190 1411 1187 153 -8 101 C
ATOM 22 CE2 PHE A 3 6.497 7.881 21.295 1.00 9.10 C
ANISOU 22 CE2 PHE A 3 1369 1041 1045 109 -29 -51 C
ATOM 23 CZ PHE A 3 5.458 8.053 22.168 1.00 8.54 C
ANISOU 23 CZ PHE A 3 1029 1178 1037 -54 -190 -51 C
ATOM 24 N SER A 4 4.678 10.500 15.375 1.00 7.69 N
ANISOU 24 N SER A 4 1045 941 934 -99 3 7 N
ATOM 25 CA SER A 4 4.901 11.237 14.159 1.00 7.58 C
ANISOU 25 CA SER A 4 1000 960 920 -31 -1 17 C
ATOM 26 C SER A 4 3.691 11.992 13.664 1.00 7.25 C
ANISOU 26 C SER A 4 1030 901 824 -46 -19 -6 C
ATOM 27 O SER A 4 2.590 11.618 13.966 1.00 8.36 O
ANISOU 27 O SER A 4 976 1079 1119 -39 -28 34 O
ATOM 28 CB SER A 4 5.335 10.249 13.109 1.00 6.93 C
ANISOU 28 CB SER A 4 780 940 912 25 49 93 C
ATOM 29 OG SER A 4 6.374 9.465 13.641 1.00 7.87 O
ANISOU 29 OG SER A 4 794 1100 1096 86 -31 92 O
HETATM 30 N AIB A 5 3.920 13.043 12.878 1.00 7.10 N
ANISOU 30 N AIB A 5 908 886 903 -58 8 9 N
HETATM 31 CA AIB A 5 2.860 13.764 12.162 1.00 7.26 C
ANISOU 31 CA AIB A 5 899 975 882 -21 6 -15 C
HETATM 32 C AIB A 5 2.006 12.779 11.370 1.00 7.62 C
ANISOU 32 C AIB A 5 974 1006 915 -96 -41 41 C
HETATM 33 O AIB A 5 0.780 12.868 11.328 1.00 7.95 O
ANISOU 33 O AIB A 5 993 1112 913 -32 -166 93 O
HETATM 34 CB1 AIB A 5 2.056 14.573 13.162 1.00 7.20 C
ANISOU 34 CB1 AIB A 5 815 913 1009 23 -38 -36 C
HETATM 35 CB2 AIB A 5 3.484 14.751 11.192 1.00 7.42 C
ANISOU 35 CB2 AIB A 5 879 976 962 -1 10 43 C
ATOM 36 N PHE A 6 2.669 11.835 10.708 1.00 8.13 N
ANISOU 36 N PHE A 6 998 1018 1070 -88 -75 -48 N
ATOM 37 CA PHE A 6 2.015 10.737 9.994 1.00 7.66 C
ANISOU 37 CA PHE A 6 893 1020 994 -117 -141 57 C
ATOM 38 C PHE A 6 3.108 9.700 9.778 1.00 7.89 C
ANISOU 38 C PHE A 6 1022 1092 884 -47 -142 -29 C
ATOM 39 O PHE A 6 4.272 10.028 9.963 1.00 8.00 O
ANISOU 39 O PHE A 6 965 1013 1058 25 -45 -114 O
ATOM 40 CB PHE A 6 1.390 11.217 8.673 1.00 7.89 C
ANISOU 40 CB PHE A 6 1036 1008 952 -18 -90 56 C
ATOM 41 CG PHE A 6 2.340 11.957 7.810 1.00 8.43 C
ANISOU 41 CG PHE A 6 1020 1099 1081 -85 -27 -2 C
ATOM 42 CD1 PHE A 6 3.029 11.299 6.820 1.00 10.53 C
ANISOU 42 CD1 PHE A 6 1546 1153 1299 81 109 -103 C
ATOM 43 CD2 PHE A 6 2.583 13.306 8.016 1.00 8.97 C
ANISOU 43 CD2 PHE A 6 1273 1034 1099 50 -62 47 C
ATOM 44 CE1 PHE A 6 3.934 11.976 6.037 1.00 11.90 C
ANISOU 44 CE1 PHE A 6 1882 1206 1432 4 272 -40 C
ATOM 45 CE2 PHE A 6 3.492 13.980 7.237 1.00 9.56 C
ANISOU 45 CE2 PHE A 6 1234 1163 1232 -17 -43 42 C
ATOM 46 CZ PHE A 6 4.166 13.315 6.244 1.00 10.33 C
ANISOU 46 CZ PHE A 6 1247 1210 1464 -10 106 15 C
HETATM 47 N AIB A 7 2.733 8.462 9.447 1.00 7.63 N
ANISOU 47 N AIB A 7 986 1068 842 -4 -173 -15 N
HETATM 48 CA AIB A 7 3.697 7.381 9.174 1.00 7.99 C
ANISOU 48 CA AIB A 7 956 1049 1029 -76 -54 -103 C
HETATM 49 C AIB A 7 4.664 7.158 10.320 1.00 9.25 C
ANISOU 49 C AIB A 7 1170 1200 1143 129 -153 -53 C
HETATM 50 O AIB A 7 5.855 7.005 10.140 1.00 9.48 O
ANISOU 50 O AIB A 7 1202 985 1414 99 -25 166 O
HETATM 51 OXT AIB A 7 4.280 7.099 11.486 1.00 9.53 O
ANISOU 51 OXT AIB A 7 1213 1262 1145 19 -130 -46 O
HETATM 52 CB1 AIB A 7 2.965 6.061 8.914 1.00 8.35 C
ANISOU 52 CB1 AIB A 7 958 1094 1118 -89 -98 -138 C
HETATM 53 CB2 AIB A 7 4.423 7.750 7.901 1.00 8.10 C
ANISOU 53 CB2 AIB A 7 990 1103 985 -25 -105 -27 C
TER 54 AIB A 7
HETATM 55 O HOH A 101 1.741 3.551 16.047 1.00 13.42 O
ANISOU 55 O HOH A 101 1818 1074 2205 -76 -150 -52 O
HETATM 56 O HOH A 102 3.395 13.194 18.990 1.00 12.04 O
ANISOU 56 O HOH A 102 1161 1343 2071 -97 -570 -32 O
CONECT 3 7
CONECT 7 3 8
CONECT 8 7 9 11 12
CONECT 9 8 10 13
CONECT 10 9
CONECT 11 8
CONECT 12 8
CONECT 13 9
CONECT 26 30
CONECT 30 26 31
CONECT 31 30 32 34 35
CONECT 32 31 33 36
CONECT 33 32
CONECT 34 31
CONECT 35 31
CONECT 36 32
CONECT 38 47
CONECT 47 38 48
CONECT 48 47 49 52 53
CONECT 49 48 50 51
CONECT 50 49
CONECT 51 49
CONECT 52 48
CONECT 53 48
MASTER 256 0 3 0 0 0 0 6 55 1 24 1
END